What is a typical time frame for Type IV hypersensitivity reactions to develop?

Correct Answer: C

Rationale: The correct answer is C (24-72 hours) for Type IV hypersensitivity reactions to develop. This type of reaction involves T cell-mediated immune responses, which take time to develop. Initially, sensitization occurs, followed by activation of memory T cells upon re-exposure to the antigen. This process typically takes 24-72 hours to manifest clinically. Choices A (Within minutes), B (1-3 hours), and D (5-7 days) are incorrect because Type IV reactions do not exhibit immediate responses like Type I hypersensitivity reactions (Choice A), nor do they typically take as long as 5-7 days to develop (Choice D). The time frame of 1-3 hours (Choice B) is too short for the characteristic delayed hypersensitivity reaction seen in Type IV responses.

Correct Answer: C

Rationale: The correct answer is C: Afferent lymphatics. Dendritic cells migrate from tissues to lymph nodes through afferent lymphatics, which are small vessels that carry lymph into the lymph nodes. Once inside the lymph nodes, dendritic cells interact with T cells to initiate immune responses. The thoracic duct (A) drains lymph from the entire body into the bloodstream, not directly into lymph nodes. High endothelial venules (HEV) (B) are specialized blood vessels in lymph nodes where lymphocytes enter from the bloodstream, not dendritic cells. Efferent lymphatics (D) carry lymph out of the lymph nodes, not into them.

Correct Answer: B

Rationale: The correct answer is B: Signal propagation in T cells. CD3 is a protein complex found on the surface of T cells that is crucial for T cell receptor signaling and activation. It helps propagate signals within T cells, leading to T cell activation and immune responses. Choice A (Antigen binding) is incorrect as CD3 is not directly involved in antigen binding. Choice C (Signal propagation in B cells) is incorrect as CD3 is specific to T cells, not B cells. Choice D (T cell homing to lymph nodes) is incorrect as CD3 is not responsible for the physical migration of T cells to lymph nodes.

Correct Answer: E

Rationale: Rationale for Correct Answer (E): E: Surgery is the correct answer. Surgery is not typically used as a primary therapy for autoimmune diseases. Autoimmune diseases are usually treated with medications such as immuno-suppressive drugs (A), anti-inflammatory drugs (B), and targeted therapies like anti-TNF (C) and anti-CD20 (D) to manage symptoms and control the immune response. Surgery is only considered in specific cases when other treatments have failed or for complications related to the autoimmune disease. Therefore, surgery is not a standard therapy for autoimmune diseases. Summary of Incorrect Choices: A: Immuno-suppressive drugs like cortisone are commonly used in autoimmune disease treatment. B: Aspirin is an anti-inflammatory drug that can help manage symptoms in some autoimmune diseases. C: Anti-TNF therapy targets specific molecules involved in the immune response in autoimmune diseases. D: Anti-CD20 therapy targets B cells to modulate the immune response in autoimmune diseases.

Correct Answer: E

Rationale: I'm sorry, but the correct answer is not provided in the choices given. Acquired passive immunity refers to the transfer of antibodies from one individual to another. Breast milk, placental transfer, short-term protection, and disease prevention are all characteristics of acquired passive immunity. Therefore, the correct answer is not presented in the options provided.